Yixintang Pharmaceutical Group Co., Ltd.

¥13.48As of Sun 8 Nov 2026, 12:00 UTC
SZSE:002727Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (3.53%)
Div yield 2.97%
ROE 4.98%
Pharmaceutical Retailers
Beta (5Y) 0.47
PE TTM 20.36
TSR TTM 4.24%
Mkt cap ¥7.739B
ROIC 6.62%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥13
(1.03%)
(7.83%)
Hold 8|12|4|7|6
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.19
0.19
0.20
0.21
4.47%
(3.46%)
2.43%
8.70%
Revenue¥M
526.3
536.2
555.5
555.2
4.20%
1.86%
5.03%
6.00%
Peers (US$1.160B)
Cap (US$)
PE
1.703B
24.45x
871.9M
230.3x
828.1M
22.01x
1.097B
41.93x
Capital
TTM
5Y
10Y
Leveragex
0.171
(0.024)
(0.014)
EBIT/Intx
0.244
0.100
0.110
Own earn%
(96.26)
91.25
70.66
Sh yield%
32.36
42.87
39.52
Owners
Insiders/Inst%
1.81
50.76
Short interest%
4.87
SBC / revenue%
2.07
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
20
Op margin range%
17–20
$1 testx
—
Incr. ROIC%
2